Fig. 1From: Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysisComparison of survival outcomes in patients who received R + TKI or TKI alone. Kaplan-Meier OS (a) and PFS (b) curves were generated. Patients included were separated into R + TKI (N = 65) and TKI-alone (N = 67) groupsBack to article page